###begin article-title 0
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
###end article-title 0
###begin p 1
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 831 836 831 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 1226 1231 1226 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 1352 1357 1352 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 62 67 <span type="species:ncbi:9606">human</span>
The RUNX3 gene is regarded as a tumor suppressor gene in many human solid tumors, and its inactivation is believed to be related with solid tumor carcinogenesis. As little information is available about the role of the RUNX3 gene in breast cancer, we investigated the relationship between the RUNX3 gene and breast cancer. We performed reverse transcriptase-polymerases chain reaction (RT-PCR), methylation specific PCR, and bicolor fluorescent in situ hybridization analysis in an effort to reveal related mechanisms. Forty breast tissue samples and 13 cell lines were used in this study. Eighty-five percent of breast cancer tissues showed downregulated RUNX3 gene expression, whereas it was downregulated in only 25% of normal breast tissues by RT-PCR assay. Sixty-seven percent of breast cancer cell lines showed downregulated RUNX3 expression, but the RUNX3 gene was not expressed in two normal breast cell lines. Hypermethylation was observed in 53% of breast cancer tissues and 57% of breast cancer cell lines. Hemizygous deletion was observed in 43% of breast cancer cell lines. Hypermethylation and/or hemizygous deletion was observed in 5 of 7 breast cancer cell lines, and the four of these five examined showed no RUNX3 gene expression. We suggest that various mechanisms, including methylation and hemizygous deletion, could contribute to RUNX3 gene inactivation.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX</italic>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX</italic>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AML</italic>
###xml 268 276 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBF&#945;</italic>
###xml 323 333 311 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEBP2&#945;</italic>
###xml 343 344 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 379 388 359 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEBP2/CBF</italic>
###xml 390 391 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 422 434 402 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX-CBF&#946;</italic>
###xml 521 522 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 524 525 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 534 538 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX</italic>
###xml 559 564 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX1</italic>
###xml 566 570 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AML1</italic>
###xml 571 576 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBFA2</italic>
###xml 577 584 554 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEBP2aB</italic>
###xml 587 592 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX2</italic>
###xml 594 598 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AML3</italic>
###xml 599 604 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBFA1</italic>
###xml 605 612 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEBP2aA</italic>
###xml 619 624 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 626 630 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AML2</italic>
###xml 631 636 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBFA3</italic>
###xml 637 644 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEBP2aC</italic>
###xml 677 678 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 681 686 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX1</italic>
###xml 727 728 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 768 769 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 816 817 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 832 833 809 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 894 899 871 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX2</italic>
###xml 920 921 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1003 1005 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1058 1060 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1082 1087 1059 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 1140 1141 1117 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1165 1167 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 113 118 <span type="species:ncbi:9606">human</span>
Recently, it has been reported that RUNX3, a RUNX family gene, is related to the carcinogeneses of various solid human tumors. The RUNX (Runt-related transcription factor) gene family is also referred to as the acute myeloid leukemia (AML), core-binding factor-alpha (CBFalpha), or polyoma enhancer-binding protein-2alpha (PEBP2alpha) family (1) and encodes the alpha-subunit of PEBP2/CBF (2). Moreover, the heterodimeric RUNX-CBFbeta complex is believed to be associated with cellular differentiation and proliferation (3, 4). Three RUNX family genes, i.e., RUNX1 (AML1/CBFA2/PEBP2aB), RUNX2 (AML3/CBFA1/PEBP2aA), and RUNX3 (AML2/CBFA3/PEBP2aC) have been detected in mammals (1). RUNX1 is believed essential in hematopoiesis (5) and is located in chromosome 21q22.3 (6). Moreover, it is targeted for translocation (7) or mutation (8) in acute and chronic leukemia or myelodysplastic syndrome. RUNX2 on chromosome 6q21 (9) is regarded as indispensable for the development of the musculoskeletal system (10) and has been related with cleidocranial dysplasia (11). On the other hand, RUNX3 gene is located on chromosome 1p36, 30.31 kb-sized (1), composed of 5 exons (12), and is believed to be associated with solid tumor carcinogenesis.
###end p 3
###begin p 4
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
Although many have reported an association between RUNX3 inactivation and solid tumor carcinogenesis, e.g., gastric cancer (13-17), colorectal cancer (18, 19), lung cancer (20-22), esophageal cancer (23), hepatocellular carcinoma (24-26), pancreatic cancer (27), and yolk sac tumor (28), others found no such correlations (29).
###end p 4
###begin p 5
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 267 272 <span type="species:ncbi:9606">human</span>
Several mechanisms including promoter region hypermethylation, loss of heterozygosity, hemizygous deletion, and mutation are believed to be correlated with the downregulation of the RUNX3 gene, and have been causally linked with the carcinogeneses in a wide range of human solid tumors.
###end p 5
###begin p 6
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
Little information is available on the relationship between the RUNX3 gene and breast cancer, other than the hypermethylation that was observed in 25% of 25 breast cancer tissues by Kim et al. (15). In order to reveal the relationship between the RUNX3 gene and breast cancer and its mode of action, we performed reverse transcriptase-polymerase chain reaction (RT-PCR), methylation-specific PCR (MSP) and bicolor fluorescent in situ hybridization (FISH) on 40 breast tissues and 13 cell lines.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Tissue collection
###end title 8
###begin p 9
###xml 610 617 <span type="species:ncbi:9606">patient</span>
Forty breast tissue samples (20 normal breast tissues and 20 breast cancer tissues) were collected for this study. These tissue samples were obtained during resective surgery, immediately frozen in liquid nitrogen, and stored at -80℃ until required for DNA and RNA extraction. Breast cancer tissue samples were macrodissected through the centers of carcinomatous regions and then normal breast tissue samples, well separate from cancer bearing regions, were macrodissected. The pathologic classification of all 20 breast cancer tissues was of infiltrating ductal carcinoma. This study was performed with given patient consent at Seoul National University Hospital.
###end p 9
###begin title 10
Cell lines
###end title 10
###begin p 11
Thirteen cell lines were used in this study. Eight cell lines (Hs 578T, MCF-7, MDA-MB-231, SCC-1395, SK-BR-3, ZR-75-1, SNU1, and SNU5) were obtained from the Korean Cell Line Bank (Seoul), and the other five (MCF10A, MCF-7 TH, MDA-MB-468, MDA-MB-436, and T-47D) from the American Type Culture Collection (ATCC). Two cell lines, SCC-1395 and MCF 10A, were used as non-cancer controls. These two cell lines originated from normal breast tissue and breast tissue showing fibrocystic change, respectively. Another two cell lines, SNU1 and SNU5, originated from gastric carcinoma. Because the SNU1 cell line is known to have only methylated DNA products by MSP, it was used as a positive control for MSP. Similarly, because the SNU5 cell line has only unmethylated DNA products, it was used as a negative control. The remaining 9 cell lines originated from breast cancer (ZR-75-1, MCF 7, SK-BR-3, Hs 578T, MDA-MB-231, T-47D, MDA-MB-436, MDA-MB-468, and MCF-7 TH).
###end p 11
###begin title 12
Cell culture
###end title 12
###begin p 13
###xml 869 870 861 862 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 200 206 <span type="species:ncbi:9913">bovine</span>
###xml 571 576 <span type="species:ncbi:9796">horse</span>
Seven cell lines, namely, SCC-1395, ZR-75-1, MCF7, T-47D, MCF-7 TH, SNU1, and SNU5, were cultured in Roswell Park Memorial Institute (RPMI) 1640 enriched with 1% penicillin/streptomycin and 10% fetal bovine serum (FBS). MDA-MB-231, MDA-MB-436, and Hs 578T were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 1% penicillin/streptomycin and 10% FBS. SK-BR-3 and MDA-MB-468 were cultured in DMEM/F-12 (Nutrient Mixture F-12) containing 1% penicillin/streptomycin and 10% FBS, and MCF 10A was cultured in DMEM/F-12 containing 1% penicillin/streptomycin, 5% horse serum (all of the above were purchased from GibcoBRL, NY, U.S.A.), 10 microg/mL insulin, 10 ng/mL epithelial growth factor, 0.5 ng/mL hydrocortisone, and 0.1 microg/mL cholera toxin (Sigma-Aldrich, St. Louis, MO). Cell culture plates were maintained in humidified incubators at 37℃ in a 5% CO2 atmosphere.
###end p 13
###begin title 14
RT-PCR
###end title 14
###begin p 15
###xml 465 470 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 531 534 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 341 347 <span type="species:ncbi:10090">Murine</span>
Total RNA was extracted from breast cancer tissues and cell lines using TRIzol(R) reagent (Invitrogen, CA, U.S.A.), and complementary DNA was synthesized from total RNA with deoxyribonucleotide triphosphate (dNTP) mix, RNase I (Ribonuclease Inhibitor), dithiothreitol (DTT), diethylpyrocarbonate (DEPC), RNA, 5 X first-stand buffer, Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase (Invitrogen) and random primer. Complementary DNA was amplified using a RUNX3 gene specific primer with complementary DNA template, dNTP, Taq polymerase, distilled water (DW), and 10X buffer. Initial denaturation was performed at 94℃ for 5 min, and this was followed by 35 amplification cycles (30 sec at 95℃, 55℃, and 72℃). Final elongation was performed at 72℃ for 10 min, and beta-actin was used as a control.
###end p 15
###begin p 16
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 76 81 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 138 143 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
The primers used to amplify RUNX3 and beta-actin were as follows: sense for RUNX3, 5'-GAG TTT CAC CCT GAC CAT CAC TGT G-3'; antisense for RUNX3, 5'-GCC CAT CAC TGG TCT TGA AGG TTG T-3' (869 base pairs); sense for beta-actin, 5'-CAC TGT GTT GGC GTA CAG GT-3'; antisense for beta-actin, 5'-TCA TCA CCA TTG GCA ATG AG-3' (155 base pairs). Electrophoresis was followed by visualization under ultraviolet light after loading the amplified PCR products on 2% agarose gel containing ethidium bromide.
###end p 16
###begin p 17
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 200 205 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 280 285 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 371 376 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
We classified the level of RUNX3 expression into 3 types such as weak, moderate, and strong expression in comparison with the expression level of beta-actin. Strong expression means that the level of RUNX3 expression is almost same with that of beta-actin. When the expression of RUNX3 is visible but very faint, we classified it as weak expression. If the expression of RUNX3 is intermediate between strong and weak, then we regard it as moderate expression.
###end p 17
###begin title 18
MSP
###end title 18
###begin p 19
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
One Day MSP kits (In2Gen Co., Seoul) were used to determine the promoter methylation status of the RUNX3 gene in genomic DNA extracted from breast cancer tissues and cell lines. Initial denaturation was performed at 95℃ for 15 min followed by 40 amplification cycles of; 95℃ (20 sec), 60℃ (40 sec), and 72℃ (60 sec). Final elongation was performed at 72℃ for 3 min.
###end p 19
###begin p 20
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
The following primers were used as previously described by Li et al. (13): sense for methylation, 5'-TTA CGA GGG GCG GTC GTA CGC GGG-3'; antisense for methylation, 5'-AAA ACG ACC GAC GCG AAC GCC TCC-3' (220 base pairs); sense for non-methylation, 5'-TTA TGA GGG GTG GTT GTA TGT GGG-3'; antisense for non-methylation, 5'-AAA ACA ACC AAC ACA AAC ACC TCC-3' (212 base pairs). After electrophoresis on 2% agarose gel containing ethidium bromide, the amplified PCR products were visualized under ultraviolet light.
###end p 20
###begin title 21
Bicolor FISH analysis
###end title 21
###begin p 22
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 475 480 <span type="species:ncbi:9606">human</span>
Cells (1x106/mL) fixed with Carnoy's solution (methanol: acetic acid, 3:1) were mixed with 0.1% Nonidet P-40 (NP-40)/2x standard saline citrate (SSC) solution for 30 min to increase cell membrane permeabilities and dehydrated for 3 min in a 70%, 85%, 100% ethanol series. All of the following procedures were performed in the dark. A probe mixture prepared from RUNX3 gene-specific probe tagged with Cy3, and a 1q21.1 specific probe tagged with FITC (control) was mixed with human Cot-1 DNA, salmon sperm DNA, and hybridization buffer. Denaturation and hybridization (DAKO, Hamburg, Germany) were performed after dropping a probe mixture on a slide containing cells followed by DAPI solution for background staining. The RUNX3 gene-specific probe was tagged with Cy3 release orange and the 1q21.1 specific probe was tagged with FITC release green.
###end p 22
###begin p 23
After performing the above, 100 cells from each cell lines were randomly observed. If the green staining exceeded the orange staining in a single cell, then the O/G (O and G mean orange and green staining, respectively) ratio was defined to be less than 1. If O/G ratios were less than 1 in more than 20% of observed cells, then hemizygous deletion of the RUNX3 gene was presumed in the affected cell line.
###end p 23
###begin title 24
RESULTS
###end title 24
###begin title 25
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
RUNX3 gene expression by RT-PCR in breast cancer tissues and cell lines
###end title 25
###begin p 26
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 221 227 221 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 229 236 229 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 551 557 551 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
RUNX3 gene expression was not observed in five (numbers 3, 8, 14, 17, and 19) of the 20 normal breast tissue samples, but only three samples (numbers 4, 5, and 9) of 20 breast cancer tissues showed RUNX3 gene expression (Fig. 1, Table 1). RUNX3 gene expression was observed in six cell lines, namely, MDA-MB-436, SCC-1395, T-47D, ZR-75-1, MCF 10A, and SNU-5 (Table 2), and whereas SNU-5 showed strong expression, three cell lines, i.e., MDA-MB-436, T-47D, and ZR-75-1, showed weak expression. Moderate expression was observed in SCC-1395 and MCF 10A (Fig. 2). The RT-PCR product sizes for the RUNX3 and beta-actin genes were 869 and 155 base pairs, respectively.
###end p 26
###begin title 27
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
Analysis of RUNX3 methylation by MSP in breast cancer tissues and cell lines
###end title 27
###begin p 28
###xml 486 492 486 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 935 941 935 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
MSP results were available in 19 of the 20 breast cancer tissues. Sample number 19 was excluded because of the insufficient amount of specimen for repeated experiments. Methylated DNA products were observed in 10 breast cancer tissues (samples 2-4, 6, 8, 10, 11, 13, 14, and 15) and unmethylated DNA products in 18 breast cancer tissues (excepting only sample 13). Nine breast cancer tissues (samples 2-4, 6, 8, 10, 11, 14, and 15) showed both methylated and unmethylated DNA products (Fig. 3). Ten out of thirteen cell lines showed the results of MSP, and results were inadequate for three cell lines, i.e., SCC-1395, Hs 578T, and T-47D. Methylated DNA products were observed in 6 cell lines, i.e., MCF7, SNU-1, MDA-MB-231, SK-BR-3, MCF-7 TH, and MCF 10A, and unmethylated DNA products in 5 cell lines, i.e., MDA-MB-436, MDA-MB-468, SK-BR-3, ZR-75-1, and SNU-5. Methylated and unmethylated DNA products were only observed in SK-BR-3 (Fig. 4). The product sizes of the methylation and unmethylation MSP primers were 220 and 212 base pairs, respectively.
###end p 28
###begin title 29
Results of bicolor FISH analysis in cell lines
###end title 29
###begin p 30
###xml 99 106 99 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 952 958 952 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
Bicolor FISH results were obtained in 9 cell lines, except SCC-1395, Hs 578T, T-47D, and MCF-7 TH (Table 3). These results were classified into 5 different patterns, i.e., normal, O/G<1, O/G>1, hypoploid, and hyperploid. If one, two, or more than 2 pairs of orange and green colors were observed in a single cell, then the cell was classified as hypoploid, normal, and hyperploid, respectively. If the amount of green was greater or smaller than the amount of orange, then the cell of interest was classified as O/G<1 or O/G>1, respectively. Because more than 20% of cells showed O/G<1 for the MB 436, MCF7, SK-BR-3, SNU-1, and SNU-5 cell lines, hemizygous deletion of the RUNX3 gene was deemed to be present in these cell lines. Less than 20% of cells showed O/G<1 in ZR-75-1, MDA MB 231, and MDA MB 468, and no cell had an O/G<1 in MCF 10A. All MCF 10A cells and 95% of ZR-75-1 cells showed a normal pattern, whereas all MCF7 cells had an O/G of <1 (Fig. 5). Only 2 cell lines, i.e., MDA MB 468 and SNU-1, had an O/G of >1, and only MDA MB 436 showed a hypoploid pattern. Seven cell lines, except MCF 10A and MCF7, showed various degrees of hyperploidy.
###end p 30
###begin title 31
DISCUSSION
###end title 31
###begin p 32
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
Recently it was reported that RUNX3 gene expression is downregulated in various solid tumors in vivo. While Li et al found that RUNX3 gene expression was downregulated in 60% of gastric cancer tissues and in 47% of gastric cancer cell lines (13), Sakakura et al. found that RUNX3 gene expression was downregulated in 78% of gastric cancer tissues and in 69% of gastric cancer cell lines (14). Regarding colorectal cancer cell lines, Ku et al. reported that 50% showed decreased RUNX3 gene expression (18), and Goel et al. found that RUNX3 gene expression was downregulated in 65% of colorectal cancer cell lines (19). Other studies have reported various degrees of RUNX3 downregulation in lung cancer, esophageal cancer, hepatocellular carcinoma, pancreatic cancer, and others. However, little data is available on the relationship between RUNX3 gene expression and breast cancer.
###end p 32
###begin p 33
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
In the present study, 85% of breast cancer tissues (17 of 20 samples) showed RUNX3 gene downregulation, whereas it was downregulated in only 25% of normal breast tissues (5 of 20) by RT-PCR. Regarding the cell lines, 67% of breast cancer cell lines (6 of 9) showed RUNX3 downregulation, although in two normal breast cell lines (SCC-1395 and MCF 10A) RUNX3 gene expression was not detected. SNU-5 is known to possess only unmethylated DNA and showed strong RUNX3 expression, and SNU-1 is known to possess only methylated DNA and showed no RUNX3 expression. Moreover, while SCC-1395 and MCF 10A showed moderate expression, 3 of 9 breast cancer cell lines (MDA-MB-436, T-47D, and ZR-75-1) showed weak expression. These results imply that RUNX3 expression is downregulated in breast cancer and that this downregulation is related its carcinogenesis, as described for other cancers above.
###end p 33
###begin p 34
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1318 1325 1318 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1327 1328 1327 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
Several genetic and epigenetic events may explain the mechanism underlying RUNX3 downregulation, such as, promoter region hypermethylation, loss of heterozygosity, microsatellite instability, hemizygous deletion, and mutation. Li et al found loss of heterozygosity in 30% of gastric cancer tissues and 20% of gastric cancer cell lines, and that hypermethylation is related to RUNX3 gene expression (13). They also have found one mutation in the RUNX3 gene among 119 gastric cancer tissue samples. Ku et al. have reported hypermethylation in 18.4% of colorectal cancer tissues and in 37.5% of colorectal cancer cell lines. Yanada et al. also found hypermethylation in 53% of lung cancer cell lines and loss of heterozygosity in 53% of lung cancer cell lines (22). Especially, promoter region hypermethylation was of very wide range from 2.5-73% in various tumor samples. Little information is available on breast cancer, but Kim et al. reported their observation of hypermethylation in 25% of 25 breast cancer tissues (15). In the present study, hypermethylation was observed in 53% (10 of 19) of breast cancer tissues and in 57% (4 of 7) breast cancer cell lines, and hemizygous deletion was observed in 43% (3 of 7) breast cancer cell lines. The results of our study on breast tissue and cell lines are summarized in Table 1, 2.
###end p 34
###begin p 35
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 196 203 196 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 835 842 835 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1420 1425 1420 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 1525 1530 1525 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 1650 1655 1650 1655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 1789 1794 1789 1794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
In breast cancer tissues, methylated DNA was found in 10 of 19 breast cancer tissues (53%), and RUNX3 gene expression was not observed in these samples except for one sample (sample 4) by RT-PCR (Table 1). Unmethylated DNA was observed in 18 breast cancer tissues (95%) except for sample 13, which showed only methylated DNA. Nine samples (47%) showed both methylated and unmethylated DNA. Although nine breast cancer tissues (47%) had only unmethylated DNA, the expression of RUNX3 gene was observed in only 2 of these samples. In addition, sample 4 showed RUNX3 expression despite having methylated DNA. These results suggest that a mechanism other than methylation of RUNX3 promoter influences RUNX3 gene expression. With regard to cell lines, MSP results were available for 10 cell lines and bicolor FISH results for 9 cell lines (Table 2). Methylated DNA was observed in 6 cell lines (MCF 10A, MCF7, SK-BR-3, MDA-MB-231, MCF-7 TH, and SNU-1), whereas four cell lines (ZR-75-1, MDA-MB-436, MDA-MB-468, and SNU-5) contained only unmethylated DNA. Only SK-BR-3 showed both methylated and unmethylated DNA. Hemizygous deletion was observed in 5 cell lines (MCF7, SK-BR-3, MDA-MB-436, SNU-1, and SNU-5), and hypermethylation and/or hemizygous deletion in five cell lines (MCF7, SK-BR-3, MDA-MB-231, MDA-MB-436, and MCF-7 TH) of 7 breast cancer cell lines with available results, and 4 of these 5 cell lines did not show RUNX3 expression. Despite the hemizygous deletion in MDA-MB-436 (which contained only unmethylated DNA), RUNX3 expression was observed. In the case of MDA-MB-468, which contained only unmethylated DNA without hemizygous deletion, RUNX3 expression was not apparent. These results imply that a mechanism other than hypermethylation or hemizygous deletion participates in RUNX3 gene expression.
###end p 35
###begin p 36
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
In conclusion, RUNX3 gene expression was found to be downregulated in breast cancer. In addition, it is evident that several mechanisms of RUNX3 gene inactivation, including methylation and hemizygous deletion, contribute to the development of breast cancer.
###end p 36
###begin title 37
ACKNOWLEDGMENT
###end title 37
###begin p 38
We thank Kyu Choon Hwang, Ph.D (In2Gen Co., Seoul) for performing the MSP experiment and Pearl Lee (BMS Co., Seoul), Hankyu Seo (BMS Co., Seoul) for valuable discussions.
###end p 38
###begin p 39
###xml 61 110 61 110 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health and Welfare, Republic of Korea</funding-source>
###xml 112 134 112 134 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">01-PJ3-PG6-01GN07-0004</award-id>
This work was supported by the Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ3-PG6-01GN07-0004).
###end p 39
###begin article-title 40
Nomenclature for Runt-related (RUNX) proteins
###end article-title 40
###begin article-title 41
Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF
###end article-title 41
###begin article-title 42
Runx transcription factors and the developmental balance between cell proliferation and differentiation
###end article-title 42
###begin article-title 43
The RUNX genes: gain or loss of function in cancer
###end article-title 43
###begin article-title 44
Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development
###end article-title 44
###begin article-title 45
###xml 59 64 <span type="species:ncbi:9606">human</span>
Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1
###end article-title 45
###begin article-title 46
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints
###end article-title 46
###begin article-title 47
Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia
###end article-title 47
###begin article-title 48
###xml 26 31 <span type="species:ncbi:9606">human</span>
AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization
###end article-title 48
###begin article-title 49
Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression
###end article-title 49
###begin article-title 50
###xml 35 40 <span type="species:ncbi:9606">human</span>
Dysregulation of chondrogenesis in human cleidocranial dysplasia
###end article-title 50
###begin article-title 51
Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain
###end article-title 51
###begin article-title 52
Causal relationship between the loss of RUNX3 expression and gastric cancer
###end article-title 52
###begin article-title 53
Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer
###end article-title 53
###begin article-title 54
###xml 41 46 <span type="species:ncbi:9606">human</span>
Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma
###end article-title 54
###begin article-title 55
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis
###end article-title 55
###begin article-title 56
Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma
###end article-title 56
###begin article-title 57
Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines
###end article-title 57
###begin article-title 58
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers
###end article-title 58
###begin article-title 59
###xml 31 36 <span type="species:ncbi:9606">human</span>
Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis
###end article-title 59
###begin article-title 60
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer
###end article-title 60
###begin article-title 61
###xml 91 96 <span type="species:ncbi:9606">human</span>
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines
###end article-title 61
###begin article-title 62
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk
###end article-title 62
###begin article-title 63
###xml 84 89 <span type="species:ncbi:9606">human</span>
Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma
###end article-title 63
###begin article-title 64
Hypermethylation of the RUNX3 gene in hepatocellular carcinoma
###end article-title 64
###begin article-title 65
Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma
###end article-title 65
###begin article-title 66
RUNX3 expression in primary and metastatic pancreatic cancer
###end article-title 66
###begin article-title 67
###xml 76 83 <span type="species:ncbi:9606">infants</span>
Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants
###end article-title 67
###begin article-title 68
Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas
###end article-title 68
###begin p 69
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 146 147 146 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
RT-PCR analysis of RUNX3 gene expression in normal and breast cancer tissues. RUNX3 downregulation was observed in 5 of 20 normal breast tissues (A), but in 17 of 20 breast cancer tissues (B).
###end p 69
###begin p 70
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
RT-PCR analysis of RUNX3 gene expression in 13 breast cell lines. RUNX3 gene expression was observed in six cell lines (MDA-MB-436, SCC-1395, T47D, ZR-75-1, MCF10A, and SNU-5). SNU-5 showed strong expression, whereas SNU-1 showed none. SCC-1395 and MCF10A showed moderate expression, and MDA-MB-436, T47D, and ZR-75-1 showed weak expression.
###end p 70
###begin p 71
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 535 540 <span type="species:ncbi:9606">human</span>
Methylation analysis of the RUNX3 gene in breast cancer tissues. The results of MSP were available for 19 samples (except sample 19; data for sample 14 is not shown in this figure.) Methylated DNAs were found in 10 samples (samples 2, 3, 4, 6, 8, 10, 11, 13, 14, and 15), and all except one (sample number 13) contained unmethylated DNAs. Nine breast cancer tissues (samples 2, 3, 4, 6, 8, 10, 11, 14, and 15) contained both methylated and unmethylated DNA. U and M denote unmethylation and methylation, respectively. N denotes normal human genomic DNA, which was used as an unmethylated PCR control, and DW is an abbreviation for distilled water, which was used as a negative PCR control.
###end p 71
###begin p 72
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 391 396 <span type="species:ncbi:9606">human</span>
Methylation analysis of the RUNX3 gene in cells. MSP results were available for 10 cell lines (except SCC-1395, Hs 578T, and T-47D). Methylated DNA was found in 6 cell lines (MCF7, SNU-1, MDA-MB-231, SK-BR-3, MCF-7 TH, and MCF 10A), and unmethylated DNA in 5 (MDA-MB-436, MDA-MB-468, SK-BR-3, ZR-75-1, and SNU-5). U and M denote unmethylation and methylation, respectively. N denotes normal human genomic DNA, which was used as an unmethylated PCR control, and DW is an abbreviation for distilled water, which was used as a negative PCR control.
###end p 72
###begin p 73
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 157 158 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 221 222 221 222 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Bicolor FISH analysis. Orange is produced by RUNX3 probe and green by control probe on 1q21.1. Ninety-five percent of ZR-75-1 cells showed a normal pattern (A), and O/G ratios of patterns were observed in all MCF7 cells (B).
###end p 73
###begin p 74
Summary of breast cancer tissue results
###end p 74
###begin p 75
RT-PCR, reverse transcriptase-polymerase chain reaction; U, unmethylation; M, methylation; -, negative; ?, unknown.
###end p 75
###begin p 76
Summary of breast cell line results
###end p 76
###begin p 77
RT-PCR, reverse transcriptase-polymerase chain reaction; FISH, fluorescent in situ hybridization; U, unmethylation; M, methylation; D, hemizygous deletion; -, negative; ?, unknown.
###end p 77
###begin p 78
Results of bicolor FISH analysis
###end p 78
###begin p 79
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 52 58 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 96 101 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RUNX3</italic>
###xml 165 178 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 224 236 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 287 295 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8741;</sup>
*Cell exhibited 2 pairs of orange and green colors; daggerThe ratio of orange (representing the RUNX3 gene) to green (control) in the observed cell was less than 1; double daggerThe ratio of orange to green was more than 1; section signCell exhibited 2 pairs of orange and green colors; parallelCell exhibited more than 2 pairs of orange and green colors.
###end p 79
###begin p 80
FISH, fluorescent in situ hybridization.
###end p 80

